Woodinville, WA – According to filings with the U.S. Securities and Exchange Commission, Briotech is raising $11,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Rick Lockett played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Briotech
BRIOTECH HOCl is a globally-focused disruptive supplier of pure HOCl and deployable remotely controlled factories for community empowerment. We produce a pure HOCl from saltwater re-synthesis that has been shown to be a virtual bio mimic of the bodys own defense system (phagocytosis in white blood cells). HOCl stops replication of virtually all pathogens without creation of resistance & persistence mechanisms (superbugs). BrioHOCl solution was tested by NIH on the worlds worst pathogens (all prion species) resulting in unprecedented results for inactivation efficacy while maintaining lasting shelf stability and consistent safety profiles.

To learn more about Briotech, visit http://www.brioglobal.com/

Contact:
Rick Lockett, Chief Executive Officer
425-488-4300
https://www.linkedin.com/in/ricklockett/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved